Anemia, Sickle Cell: all 1,125 studies
Page 11 of 12. Open to participants first (238), then studies with results posted, then the rest; newest registration first within each.
- Iron Overload and Growth Velocity in Thalassemia and Sickle Cell AnemiaCompletedNCT00972231
- Blood Transfusions in Thalassemia Patients, Complications and Adverse EffectsCompletedNCT00971880
- The Spleen in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00971698
- Sickle Cell Disease Conditioning for Bone Marrow TransplantCompletedNCT00968162Phase 1
- Exercise-induced Pulmonary Hypertension in Patients With Sickle-cell AnemiaCompletedNCT00948012
- Endothelial Function in Patients With Sickle Cell Anemia Before and After SildenafilWithdrawnNCT00937144Phase 4
- Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease - Sickle With Ibuprofen & MorphineTerminatedNCT00880373Phase 4
- Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic StrategyCompletedNCT00874172Not applicable
- Parent Educational Program for Children With Sickle Cell DiseaseCompletedNCT00860782Not applicable
- A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary HypertensionWithdrawnNCT00850369Phase 2
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention StudyCompletedNCT00850018Phase 1
- Long Term Effects of Erythrocyte LysisCompletedNCT00842621
- Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 Administered Daily in Patients With Sickle Cell DiseaseCompletedNCT00842088Phase 1/2
- Skin and Blood Research Samples From Healthy Volunteers and Patients With Hematologic DiseasesTerminatedNCT00840567Not applicable
- Validation of the Sickle Cell Disease Pain Burden InterviewCompletedNCT00804362
- Inflammatory Response to Hydroxyurea Therapy in Sickle Cell DiseaseCompletedNCT00784082
- Sickle Cell Disease and Endothelial Progenitor Cells (EPCs)CompletedNCT00783627
- Phase I/II Pilot Study of Mixed Chimerism to Treat HemoglobinopathiesCompletedNCT00777231Phase 1/2
- TRF-1101 Assessment in Sickle Cell DiseaseTerminatedNCT00773890Phase 1/2
- Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study)CompletedNCT00748423Phase 2/3
- Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With FeverCompletedNCT00736060
- Clinical Diagnosis of Teenagers Admitted to Pediatric DepartmentsCompletedNCT00735540
- Sickle Cell Anemia Screening and Prevention in Northern IsraelCompletedNCT00735488
- Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood CellsCompletedNCT00730314Phase 1/2
- Comparison of Patient Controlled Analgesia (PCA) Versus Bolus Narcotic Therapy for the Treatment of Vaso-Occlusive Crisis (VOC)WithdrawnNCT00711698Phase 2
- Screening for Subjects to Participate in Studies of Blood DisordersCompletedNCT00695123
- Adherence to Hydroxyurea in Children With Sickle Cell AnemiaCompletedNCT00672789Not applicable
- Bone Marrow for Hemoglobinopathy ResearchCompletedNCT00669305
- Kidney Transplantation in Patients With Sickle Cell DiseaseTerminatedNCT00663507
- Phase 1 Study of Zoledronic Acid in Sickle Cell DiseaseWithdrawnNCT00639392Phase 1/2
- Ranibizumab for Neovascularization in Sickle Cell RetinopathyWithdrawnNCT00618644Not applicable
- Far Infrared Radiation for Sickle Cell Pain ManagementStatus unknownNCT00599482Phase 1
- Assessing Function in Pediatric Patients With Sickle Cell DiseaseCompletedNCT00590148
- Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of ErythropoiesisCompletedNCT00578435Phase 2
- Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell DiseaseCompletedNCT00560261Phase 3
- Tadalafil for Treatment of Priapism in Men With Sickle Cell AnemiaWithdrawnNCT00538564Phase 2
- Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])TerminatedNCT00529061
- Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)TerminatedNCT00528203
- Hydroxyurea in Young Children With Sickle Cell AnemiaCompletedNCT00519701Not applicable
- Assessment of Opioid Analgesia in Sickle CellWithdrawnNCT00513864Phase 4
- Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS)TerminatedNCT00512577Phase 3
- Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00512564
- Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00512226Not applicable
- Niacin to Improve Blood Flow in People With Sickle Cell DiseaseCompletedNCT00508989Phase 2
- Pulmonary Hypertension, Hypoxia and Sickle Cell DiseaseCompletedNCT00495638
- Sickle Cell Anemia in an Arab Bedouin Village in the Northern IsraelCompletedNCT00481039
- Long Term Follow up in Sickle Cell Patients Treated by HydroxyureaCompletedNCT00480974
- Invasive Infections in Children With HemoglobinopathiesCompletedNCT00456443
- The Link Between Anemia and Deficits in Memory and Attention in Individuals With Sickle Cell DiseaseCompletedNCT00451919
- Role of Placenta Growth Factor in Sickle Acute Chest SyndromeCompletedNCT00448370
- Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell DiseaseStatus unknownNCT00434902
- IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest SyndromeCompletedNCT00434473Phase 2
- Prevention Of Morbidity In Sickle Cell Disease Pilot PhaseStatus unknownNCT00415727Phase 2
- Stem Cell Transplant in Sickle Cell Disease and ThalassemiaActive, not recruitingNCT00408447Phase 2
- Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow VelocityCompletedNCT00402480Phase 2
- Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell AnemiaCompletedNCT00399074Phase 3
- Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell DiseaseCompletedNCT00393250Phase 3
- Pain Management Protocol for Pediatric Sickle Cell DiseaseCompletedNCT00386048
- Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants.TerminatedNCT00368186Phase 4
- Pulmonary Hypertension in Patients With Sickle Cell Disease in NigeriaCompletedNCT00367523
- A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET StudyTerminatedNCT00360087Phase 3
- PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell DiseaseStatus unknownNCT00343954Phase 1
- MAST - Magnesium for Sickle Cell Acute Crisis in ChildrenCompletedNCT00313963Phase 3
- Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)TerminatedNCT00313196Phase 3
- Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)TerminatedNCT00310830Phase 3
- Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell DiseaseCompletedNCT00305175
- A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea TherapyTerminatedNCT00294541Phase 3
- Dipyridamole/Magnesium To Improve Sickle Cell HydrationWithdrawnNCT00276146Phase 2
- Hydroxyurea and Erythropoietin to Treat Sickle Cell AnemiaCompletedNCT00270478Phase 1
- SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell DiseaseTerminatedNCT00257543Early Phase 1
- Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell DiseaseTerminatedNCT00252122Phase 4
- Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a LifeportCompletedNCT00246077
- Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough PainCompletedNCT00236093Phase 2
- Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCDCompletedNCT00228631
- Study of Blood Platelets in Sickle Cell DiseaseWithdrawnNCT00226083
- Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell DiseaseCompletedNCT00186810Phase 2
- Codeine in Sickle Cell DiseaseCompletedNCT00174538Phase 1/2
- Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial UltrasoundCompletedNCT00152113Phase 1
- Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell DiseaseCompletedNCT00143572Phase 1
- Inhaled Nitric Oxide for Pediatric Painful Sickle CrisisTerminatedNCT00142051Phase 2
- Kid Cards: Teaching Kids About MedicinesWithdrawnNCT00127543Not applicable
- Heart Disease in Sickle Cell AnemiaCompletedNCT00113152
- A Stratified Sickle Event Randomized Trial (ASSERT)TerminatedNCT00102791Phase 3
- Therapeutic Application of Intravascular Nitrite for Sickle Cell DiseaseCompletedNCT00095472Phase 1
- Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell DiseaseCompletedNCT00072826Phase 1
- Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood TransfusionsCompletedNCT00067080Phase 2
- Home Based Massage and Relaxation for Sickle Cell PainCompletedNCT00066079Phase 2
- Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUGCompletedNCT00059293
- Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell AnemiaCompletedNCT00056433Phase 1
- Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric OxideTerminatedNCT00041574Phase 2
- A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.CompletedNCT00040677Phase 2
- Bone Marrow Transplant From Related Donor for Patients With High Risk HemoglobinopathiesTerminatedNCT00040469Phase 2
- Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk HemoglobinopathiesTerminatedNCT00040417Phase 2
- Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP IICompletedNCT00037388
- Pain in Sickle Cell Epidemiologic StudyCompletedNCT00035763
- Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or ThalassemiaTerminatedNCT00034528Phase 2
- Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease PatientsCompletedNCT00029731Phase 2
- Induction of Stable Chimerism for Sickle Cell AnemiaCompletedNCT00029393Phase 2
- Cord Blood Transplantation for Sickle Cell Anemia and ThalassemiaCompletedNCT00029380Phase 2
- Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary HypertensionCompletedNCT00023296Phase 1